Total Funding
28
Total FundingVenture - Series Unknown raised
Growth Score
pts
Heat Score
-15 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
Adeniosc engages in the control of blood brain barrier permeability to improve treatment for multiple central nervous system diseases.
About the Company
Adenios technology both raises and lowers the permeability of the blood brain barrier to precisely control the delivery of existing drugs. The technology, spun out of Cornell University, can be paired with unmodified current therapeutics to either improve or block delivery of multiple compounds into the brain. The technology platform is currently
in pre-clinical development aimed at controlling delivery of therapeutics for treatment of Alzheimer's, Parkinson's, brain cancer, multiple sclerosis, and other central nervous system diseases.
Women Founded
